CRISM Therapeutics Corporation (AIM:CRTX)
10.75
-0.25 (-2.28%)
Jul 29, 2025, 4:35 PM GMT+1
CRISM Therapeutics Revenue
In the year 2024, CRISM Therapeutics had annual revenue of 25.00K GBP, down -44.44%.
Revenue
25.00K
Revenue Growth
-44.44%
P/S Ratio
171.84
Revenue / Employee
6.25K
Employees
4
Market Cap
4.30M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 25.00K | -20.00K | -44.44% |
Dec 31, 2023 | 45.00K | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |
CRISM Therapeutics News
- 4 weeks ago - AIM Market Roundup: Mobile Tornado, Mediazest, Pri0r1ty Intelligence - The Armchair Trader
- 3 months ago - AIM Market Roundup: Surface Transforms, AFC Energy, Empyrean Energy - The Armchair Trader